|
US5989579A
(en)
*
|
1986-10-02 |
1999-11-23 |
Escalon Medical Corp. |
Ocular insert with anchoring protrusions
|
|
US5322691A
(en)
*
|
1986-10-02 |
1994-06-21 |
Sohrab Darougar |
Ocular insert with anchoring protrusions
|
|
KR0185215B1
(ko)
*
|
1990-11-30 |
1999-05-01 |
요시다 쇼오지 |
서방성 안구삽입용 약제
|
|
WO1994008538A1
(fr)
*
|
1992-10-22 |
1994-04-28 |
Aktsionernoe Obschestvo 'olvik' |
Membrane oculaire medicinale et son procede de production
|
|
ATE195065T1
(de)
*
|
1993-02-26 |
2000-08-15 |
Santen Pharmaceutical Co Ltd |
Biologisch abbaubarer sklerastopfen
|
|
AU731486B2
(en)
*
|
1993-11-15 |
2001-03-29 |
Allergan, Inc. |
Biocompatible ocular implants
|
|
US5443505A
(en)
*
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5773021A
(en)
*
|
1994-03-14 |
1998-06-30 |
Vetoquinol S.A. |
Bioadhesive ophthalmic insert
|
|
US5466233A
(en)
*
|
1994-04-25 |
1995-11-14 |
Escalon Ophthalmics, Inc. |
Tack for intraocular drug delivery and method for inserting and removing same
|
|
US6063396A
(en)
*
|
1994-10-26 |
2000-05-16 |
Houston Biotechnology Incorporated |
Methods and compositions for the modulation of cell proliferation and wound healing
|
|
US6063116A
(en)
*
|
1994-10-26 |
2000-05-16 |
Medarex, Inc. |
Modulation of cell proliferation and wound healing
|
|
US5516808A
(en)
*
|
1994-10-27 |
1996-05-14 |
Sawaya; Assad S. |
Topical cellulose pharmaceutical formulation
|
|
US6369116B1
(en)
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US5855915A
(en)
*
|
1995-06-30 |
1999-01-05 |
Baylor University |
Tablets or biologically acceptable implants for long-term antiinflammatory drug release
|
|
US5773019A
(en)
*
|
1995-09-27 |
1998-06-30 |
The University Of Kentucky Research Foundation |
Implantable controlled release device to deliver drugs directly to an internal portion of the body
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US5888493A
(en)
*
|
1996-12-05 |
1999-03-30 |
Sawaya; Assad S. |
Ophthalmic aqueous gel formulation and related methods
|
|
DE19718826A1
(de)
*
|
1997-05-05 |
1998-11-12 |
Marion S Dr Eckmiller |
Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
|
|
JP2001513369A
(ja)
*
|
1997-08-11 |
2001-09-04 |
アラーガン・セイルズ・インコーポレイテッド |
改善された生物適合性を有する無菌の生物侵食性の移植デバイスおよび方法
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
US6309374B1
(en)
|
1998-08-03 |
2001-10-30 |
Insite Vision Incorporated |
Injection apparatus and method of using same
|
|
US6113638A
(en)
*
|
1999-02-26 |
2000-09-05 |
Williams; Lytton A. |
Method and apparatus for intervertebral implant anchorage
|
|
US6464724B1
(en)
|
1999-04-26 |
2002-10-15 |
Gmp Vision Solutions, Inc. |
Stent device and method for treating glaucoma
|
|
DE19947711B4
(de)
*
|
1999-10-04 |
2004-02-12 |
Schrage, Norbert, Priv. Doz. Dr.med. |
Implantat zum Eisatz in der Glaukomtherapie
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
CA2383499C
(en)
*
|
1999-10-21 |
2009-11-24 |
Alcon Universal Ltd. |
Drug delivery device
|
|
JP2003511204A
(ja)
|
1999-10-21 |
2003-03-25 |
アルコン，インコーポレイティド |
テノン下薬剤送出
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6852688B2
(en)
|
2000-03-10 |
2005-02-08 |
University Of Florida |
Compositions for treating diabetic retinopathy and methods of using same
|
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
|
US6692759B1
(en)
*
|
2000-06-28 |
2004-02-17 |
The Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
EP1637126B1
(de)
*
|
2000-07-05 |
2016-12-14 |
Allergan, Inc. |
Verfahren zur Behandlung von entzündungsbedingten Zuständen der Augen
|
|
DE60135352D1
(de)
*
|
2000-08-30 |
2008-09-25 |
Univ Johns Hopkins |
Vorrichtung zur intraokularen wirkstoffverabreichung
|
|
JP3780333B2
(ja)
*
|
2000-09-22 |
2006-05-31 |
国立大学法人大阪大学 |
外来性遺伝物質又は生理活性物質を細胞内へ導入する新規な方法
|
|
WO2002058730A2
(en)
*
|
2000-11-01 |
2002-08-01 |
Allergan, Inc. |
Compositions for treatment of ocular neovascularization
|
|
US20030082183A1
(en)
*
|
2000-11-01 |
2003-05-01 |
Wheeler Larry A. |
Methods and compositions for treatment of ocular neovascularization and neural injury
|
|
EP1621219A3
(de)
*
|
2000-11-29 |
2006-03-22 |
Allergan, Inc. |
Intraokulare Implantate zur Verhinderung von Transplantatabstossung im Auge
|
|
EP1339438B1
(de)
|
2000-11-29 |
2005-10-19 |
Allergan Inc. |
Verhinderung von transplantatabstossung im auge
|
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
|
WO2002080811A2
(en)
|
2001-04-07 |
2002-10-17 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
|
EP1387671A1
(de)
|
2001-05-03 |
2004-02-11 |
MASSACHUSETTS EYE & EAR INFIRMARY |
Implantierbare arzneistoffverabreichungsvorrichtung und verwendung derselben
|
|
US7094225B2
(en)
|
2001-05-03 |
2006-08-22 |
Glaukos Corporation |
Medical device and methods of use of glaucoma treatment
|
|
EP1404297B1
(de)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
|
US7592016B2
(en)
*
|
2001-06-28 |
2009-09-22 |
Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
WO2003009774A2
(en)
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
AU2002319606B2
(en)
*
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
US6482428B1
(en)
*
|
2001-08-13 |
2002-11-19 |
Philip S Li |
Weighted eyelid implant
|
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
|
KR101173497B1
(ko)
*
|
2002-03-11 |
2012-08-14 |
알콘, 인코퍼레이티드 |
이식 가능한 약물 전달 시스템
|
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
|
ES2295647T3
(es)
*
|
2002-07-15 |
2008-04-16 |
Alcon, Inc. |
Composiciones de implante farmaceuticas lipofilas, no polimeras, para uso intraocular.
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
|
WO2004026347A2
(en)
*
|
2002-09-17 |
2004-04-01 |
Iscience Surgical Corporation |
Apparatus and method for surgical bypass of aqueous humor
|
|
US7468065B2
(en)
|
2002-09-18 |
2008-12-23 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
|
US6899717B2
(en)
*
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
CN1301692C
(zh)
|
2002-09-18 |
2007-02-28 |
阿勒根公司 |
眼植入物导入的器械
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
US20040137059A1
(en)
|
2003-01-09 |
2004-07-15 |
Thierry Nivaggioli |
Biodegradable ocular implant
|
|
WO2004073608A2
(en)
*
|
2003-02-20 |
2004-09-02 |
Alcon, Inc. |
Formulations of glucocorticoids to treat pathologic ocular angiogenesis
|
|
WO2004073607A2
(en)
*
|
2003-02-20 |
2004-09-02 |
Alcon, Inc. |
Use of steroids to treat ocular disorders
|
|
CA2524271C
(en)
|
2003-05-02 |
2012-09-04 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
|
US7589107B2
(en)
*
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US20070043006A1
(en)
*
|
2003-06-13 |
2007-02-22 |
Bingaman David P |
Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
|
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
|
KR20060085246A
(ko)
|
2003-09-18 |
2006-07-26 |
마커사이트, 인코포레이티드 |
경공막 전달
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
CA2546042A1
(en)
|
2003-11-20 |
2005-06-09 |
Othera Pharmaceuticals, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
|
EP1711196A4
(de)
|
2003-12-05 |
2011-09-14 |
Bristol Myers Squibb Co |
Inhibitoren von typ-2 vaskulären endothelialen wachstumsfaktor-rezeptoren
|
|
DE602005011928D1
(de)
|
2004-01-20 |
2009-02-05 |
Allergan Inc |
Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
|
|
US7691381B2
(en)
*
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
AU2011213904B2
(en)
*
|
2004-04-30 |
2014-06-05 |
Allergan, Inc. |
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
|
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
WO2005107708A1
(en)
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase inhibitors implants
|
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
WO2005110374A1
(en)
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US8685435B2
(en)
*
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US7771742B2
(en)
*
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US20070212395A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Allergan, Inc. |
Ocular therapy using sirtuin-activating agents
|
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
|
US8591885B2
(en)
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US7108718B1
(en)
|
2004-07-12 |
2006-09-19 |
Philip Shihua Li |
Gold eyelid weight implant
|
|
US8246569B1
(en)
|
2004-08-17 |
2012-08-21 |
California Institute Of Technology |
Implantable intraocular pressure drain
|
|
ATE515288T1
(de)
|
2004-09-24 |
2011-07-15 |
Rfe Pharma Llc |
Carboxy-amido-triazole zur lokalisierten behandlung von augenerkrankungen
|
|
US20160106717A1
(en)
|
2004-09-24 |
2016-04-21 |
Gen Pharma Holdings LLC |
Cai-based systems and methods for the localized treatment of uveitis
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US20060073172A1
(en)
*
|
2004-10-01 |
2006-04-06 |
Schneider L W |
Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
|
|
KR101341359B1
(ko)
|
2004-10-01 |
2013-12-13 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
WO2006068921A2
(en)
*
|
2004-12-22 |
2006-06-29 |
Alcon, Inc. |
Device for ophthalmic drug delivery
|
|
DK1848431T3
(en)
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
US20100196509A1
(en)
|
2005-02-28 |
2010-08-05 |
Jonathan Braun |
Methods for Diagnosis and Treatment of Endometrial Cancer
|
|
US20060204548A1
(en)
*
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
|
US20060233858A1
(en)
*
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
|
US8318906B2
(en)
|
2005-04-15 |
2012-11-27 |
The Regents Of The University Of California |
EMP2 antibodies and their therapeutic uses
|
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
US20060258994A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
|
US20080312283A1
(en)
*
|
2005-05-26 |
2008-12-18 |
Othera Pharmaceuticals, Inc. |
Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
|
|
US20100004156A1
(en)
|
2005-07-27 |
2010-01-07 |
Shalesh Kaushal |
Small Compounds That Correct Protein Misfolding and Uses Thereof
|
|
US20070134244A1
(en)
*
|
2005-10-14 |
2007-06-14 |
Alcon, Inc. |
Combination treatment for pathologic ocular angiogenesis
|
|
MX339797B
(es)
*
|
2005-10-18 |
2016-06-10 |
Allergan Inc |
Terapia ocular que usa derivados glucocorticoides que penetran selectivamente los tejidos del segmento posterior.
|
|
EA016227B1
(ru)
|
2005-11-29 |
2012-03-30 |
Смитклайн Бичем Корпорейшн |
Способ лечения офтальмологических неоваскулярных расстройств
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
JP2009531283A
(ja)
|
2006-02-02 |
2009-09-03 |
アラーガン、インコーポレイテッド |
眼系疾患の処置のための組成物および方法
|
|
KR20140093764A
(ko)
|
2006-02-09 |
2014-07-28 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
US20070202186A1
(en)
|
2006-02-22 |
2007-08-30 |
Iscience Interventional Corporation |
Apparatus and formulations for suprachoroidal drug delivery
|
|
EP2319558B1
(de)
|
2006-03-14 |
2014-05-21 |
University Of Southern California |
Mems-Vorrichtung zur Wirkstofffreisetzung
|
|
ES2563288T3
(es)
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
|
SG170816A1
(en)
|
2006-03-31 |
2011-05-30 |
Qlt Plug Delivery Inc |
Drug delivery methods, structures, and compositions for nasolacrimal system
|
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US9039761B2
(en)
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
|
CN101522133B
(zh)
*
|
2006-08-08 |
2012-08-08 |
伊纳斯米特基金会 |
可植入的光学系统，其开发和应用的方法
|
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
|
US8039010B2
(en)
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
WO2008061043A2
(en)
|
2006-11-10 |
2008-05-22 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
|
MX2009005466A
(es)
|
2006-11-22 |
2009-08-17 |
Adnexus A Bristol Myers Sqibb |
Terapeuticos dirigidos a base de proteinas manipuladas para receptores de tirosina cinasas, incluyendo receptor de factor de crecimiento tipo insulina-i.
|
|
US8969415B2
(en)
*
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
EP2091482A2
(de)
|
2006-12-01 |
2009-08-26 |
Allergan, Inc. |
Verfahren zur bestimmung optimaler intraokularer standorte für systeme zur verabreichung von medikamenten
|
|
US8846073B2
(en)
*
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
|
US8231892B2
(en)
*
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
|
WO2011063161A2
(en)
|
2009-11-20 |
2011-05-26 |
The Regents Of The University Of California |
Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr)
|
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
|
EP2214608B1
(de)
|
2007-11-08 |
2015-03-04 |
Alimera Sciences, Inc. |
Okulare implantationsvorrichtung
|
|
JP5542691B2
(ja)
|
2007-12-20 |
2014-07-09 |
ユニバーシティ オブ サザン カリフォルニア |
治療薬を送達するための装置および方法
|
|
ES2577502T3
(es)
|
2008-01-03 |
2016-07-15 |
University Of Southern California |
Dispositivos implantables de administración de fármacos y aparato para recargar los dispositivos
|
|
AU2009213141A1
(en)
|
2008-02-14 |
2009-08-20 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins that bind EGFR
|
|
US8231608B2
(en)
*
|
2008-05-08 |
2012-07-31 |
Minipumps, Llc |
Drug-delivery pumps and methods of manufacture
|
|
CN102202706A
(zh)
|
2008-05-08 |
2011-09-28 |
迷你泵有限责任公司 |
可植入药物传送装置与用于填充该装置的设备和方法
|
|
US9333297B2
(en)
|
2008-05-08 |
2016-05-10 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
|
EP2320989B1
(de)
*
|
2008-05-08 |
2015-03-11 |
MiniPumps, LLC |
Implantierbare pumpen und kanülen dafür
|
|
WO2009142773A2
(en)
|
2008-05-22 |
2009-11-26 |
Bristol-Myers Squibb Company |
Multivalent fibronectin based scaffold domain proteins
|
|
US8821870B2
(en)
|
2008-07-18 |
2014-09-02 |
Allergan, Inc. |
Method for treating atrophic age related macular degeneration
|
|
CA2742802C
(en)
|
2008-11-10 |
2019-11-26 |
Alexion Pharmaceuticals, Inc. |
Methods and compositions for treating complement-associated disorders
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
US8034813B2
(en)
*
|
2008-11-18 |
2011-10-11 |
Bausch & Lomb Incorporated |
Polymorphs of brimonidine pamoate
|
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
|
|
US8545554B2
(en)
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
|
US8425473B2
(en)
|
2009-01-23 |
2013-04-23 |
Iscience Interventional Corporation |
Subretinal access device
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
JP2012518408A
(ja)
|
2009-02-24 |
2012-08-16 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
治療用ｔｐｏ／ｅｐｏ模倣ペプチドを含む抗体
|
|
JP5342301B2
(ja)
*
|
2009-03-30 |
2013-11-13 |
三菱重工業株式会社 |
太陽光集光受熱器
|
|
US8632511B2
(en)
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
|
EP2432420A4
(de)
|
2009-05-18 |
2018-01-10 |
Dose Medical Corporation |
Arzneimittelfreisetzendes augenimplantat
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
WO2010148352A1
(en)
|
2009-06-19 |
2010-12-23 |
Altos Vision Limited |
Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
|
|
CA2766565A1
(en)
|
2009-06-23 |
2010-12-29 |
Alexion Pharmaceuticals, Inc. |
Bispecific antibodies that bind to complement proteins
|
|
JP5758388B2
(ja)
|
2009-08-18 |
2015-08-05 |
ミニパンプス， エルエルシー |
適応制御を有する電解質薬物送達ポンプ
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
CA2779104C
(en)
*
|
2009-10-30 |
2018-07-17 |
Aton Pharma, Inc. |
Ocular drug delivery devices
|
|
DK2498783T3
(en)
|
2009-11-09 |
2018-12-10 |
Allergan Inc |
COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
|
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
|
CN102821753A
(zh)
|
2010-01-22 |
2012-12-12 |
阿勒根公司 |
前房内持续释放治疗药植入物
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
JP5852968B2
(ja)
|
2010-02-19 |
2016-02-03 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
上皮膜タンパク質２（ｅｍｐ２）結合試薬および眼疾患治療におけるその使用
|
|
MX340696B
(es)
|
2010-04-30 |
2016-07-21 |
Alexion Pharma Inc |
Anticuerpos anti-c5a y metodos para usar los anticuerpos.
|
|
JP6023703B2
(ja)
|
2010-05-26 |
2016-11-09 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
改善された安定性を有するフィブロネクチンをベースとする足場タンパク質
|
|
SG186397A1
(en)
|
2010-06-22 |
2013-01-30 |
Univ Colorado Regents |
Antibodies to the c3d fragment of complement component 3
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
CN103209664A
(zh)
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
|
EP3861969A1
(de)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injektorvorrichtung zur arzneimittelabgabe
|
|
JP5996544B2
(ja)
|
2010-10-15 |
2016-09-21 |
クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ |
眼球アクセス用装置
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
EP2654715B1
(de)
|
2010-11-24 |
2017-01-25 |
Dose Medical Corporation |
Arzneimittelfreisetzendes augenimplantat
|
|
WO2012106634A1
(en)
|
2011-02-03 |
2012-08-09 |
Alexion Pharmaceuticals, Inc. |
Use of an anti-cd200 antibody for prolonging the survival of allografts
|
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US10286146B2
(en)
|
2011-03-14 |
2019-05-14 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US9603997B2
(en)
|
2011-03-14 |
2017-03-28 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
US11363951B2
(en)
|
2011-09-13 |
2022-06-21 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
|
CA2849192C
(en)
|
2011-10-12 |
2019-09-24 |
Ascendis Pharma Ophthalmology Division A/S |
Prevention and treatment of ocular conditions
|
|
WO2013082000A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
MX351261B
(es)
|
2012-06-01 |
2017-10-06 |
Surmodics Inc |
Aparato y método para recubrir catéteres con globo.
|
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
JP2015535212A
(ja)
|
2012-08-17 |
2015-12-10 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト |
補体活性化を検出するための組成物および方法
|
|
US10413620B2
(en)
|
2012-08-17 |
2019-09-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
|
|
US11090468B2
(en)
|
2012-10-25 |
2021-08-17 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
MX373894B
(es)
|
2012-11-08 |
2020-07-09 |
Clearside Biomedical Inc |
Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
|
|
JP6100008B2
(ja)
*
|
2013-02-06 |
2017-03-22 |
正敏 村田 |
生体用インプラント
|
|
EP2956096A1
(de)
|
2013-02-15 |
2015-12-23 |
Allergan, Inc. |
Implantat mit langzeit-wirkstofffreisetzung
|
|
WO2014164703A1
(en)
|
2013-03-11 |
2014-10-09 |
University Of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
EP2978451B1
(de)
|
2013-03-29 |
2019-11-27 |
Alexion Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur erhöhung der serumhalbwertzeit eines therapeutisches mittel gegen komplement-c5
|
|
BR112015027762A2
(pt)
|
2013-05-03 |
2017-08-29 |
Clearside Biomedical Inc |
Aparelho e métodos para injeção ocular
|
|
SI3011345T1
(sl)
|
2013-08-07 |
2017-12-29 |
Alexion Pharmaceuticals, Inc. |
Biomarkerski proteini za atipični hemolitični uremični sindrom (ahus)
|
|
PT3062775T
(pt)
|
2013-10-31 |
2018-03-06 |
Allergan Inc |
Implantes intraoculares contendo prostamida e métodos para a sua utilização
|
|
EP3068372B1
(de)
|
2013-11-14 |
2019-05-08 |
EyeD Pharma |
Augenvorrichtung
|
|
US10010447B2
(en)
|
2013-12-18 |
2018-07-03 |
Novartis Ag |
Systems and methods for subretinal delivery of therapeutic agents
|
|
NZ631007A
(en)
|
2014-03-07 |
2015-10-30 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
ES2803102T3
(es)
|
2014-07-15 |
2021-01-22 |
Forsight Vision4 Inc |
Dispositivo de administración de implante ocular
|
|
RU2017105844A
(ru)
|
2014-08-08 |
2018-09-11 |
Форсайт Вижн4, Инк. |
Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
|
|
EA035898B1
(ru)
|
2014-10-03 |
2020-08-28 |
НАНОТИКС, ЭлЭлСи |
Композиции и способы для ингибирования биологической активности растворимых биомолекул
|
|
CN110478119B
(zh)
|
2014-11-10 |
2022-04-15 |
弗赛特影像4股份有限公司 |
可膨胀药物递送装置和使用方法
|
|
TWM508597U
(zh)
|
2014-12-05 |
2015-09-11 |
Zhong He Ya Co Ltd |
液體加壓幫浦出力軸潤滑結構
|
|
CN107428818A
(zh)
|
2015-01-29 |
2017-12-01 |
密西根州立大学校董会 |
隐藏多肽及其用途
|
|
WO2016145389A1
(en)
|
2015-03-12 |
2016-09-15 |
Board Of Trustees Of Michigan State University |
Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases
|
|
EP3736287A1
(de)
|
2015-05-11 |
2020-11-11 |
The Johns Hopkins University |
Autoimmunantikörper zur verwendung in der hemmung des krebszellenwachstums
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
WO2017087902A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
US10390901B2
(en)
|
2016-02-10 |
2019-08-27 |
Clearside Biomedical, Inc. |
Ocular injection kit, packaging, and methods of use
|
|
WO2017173327A1
(en)
|
2016-03-31 |
2017-10-05 |
The Schepens Eye Research Institute, Inc. |
Endomucin inhibitor as an anti-angiogenic agent
|
|
CN113017981B
(zh)
|
2016-04-05 |
2023-07-25 |
弗赛特影像4股份有限公司 |
药物递送装置
|
|
WO2017176762A1
(en)
|
2016-04-06 |
2017-10-12 |
Nanotics, Llc |
Particles comprising subparticles or nucleic acid scaffolds
|
|
AU2017252294B2
(en)
|
2016-04-20 |
2021-12-02 |
Glaukos Corporation |
Bioresorbable ocular drug delivery device
|
|
EP3452165A1
(de)
|
2016-05-02 |
2019-03-13 |
Clearside Biomedical, Inc. |
Systeme und verfahren zur verabreichung eines augenmedikaments
|
|
CA3024618A1
(en)
|
2016-05-27 |
2017-11-30 |
Alexion Pharmaceuticals, Inc. |
Methods for treatment of refractory generalized myasthenia gravis
|
|
US10463532B2
(en)
|
2016-07-26 |
2019-11-05 |
Masatoshi Murata |
Method for placing implant in choroid that can less invasively and simply place implant in choroid in optic disc-macula area
|
|
IL305537B2
(en)
|
2016-08-12 |
2025-02-01 |
Clearside Biomedical Inc |
Devices and methods for adjusting the insertion depth of a needle for administering a drug
|
|
EP4520828A3
(de)
|
2016-11-15 |
2025-07-09 |
The Schepens Eye Research Institute, Inc. |
Zusammensetzungen und verfahren zur behandlung von aberranter angiogenese
|
|
US12090294B2
(en)
|
2017-05-02 |
2024-09-17 |
Georgia Tech Research Corporation |
Targeted drug delivery methods using a microneedle
|
|
US20190062428A1
(en)
|
2017-06-19 |
2019-02-28 |
Surface Oncology, Inc. |
Combination of anti-cd47 antibodies and cell death-inducing agents, and uses thereof
|
|
AU2018301393B2
(en)
|
2017-07-11 |
2025-02-27 |
Compass Therapeutics Llc |
Agonist antibodies that bind human CD137 and uses thereof
|
|
DK3658184T5
(da)
|
2017-07-27 |
2024-08-26 |
Alexion Pharma Inc |
Højkoncentrerede anti-c5-antistofformuleringer
|
|
WO2019033119A1
(en)
|
2017-08-11 |
2019-02-14 |
Unity Biotechnology, Inc. |
TREATMENT OF OPHTHALMIC CONDITIONS SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS
|
|
EP3684811A2
(de)
|
2017-08-17 |
2020-07-29 |
Massachusetts Institute of Technology |
Multispezifitätsbinder von cxc-chemokinen und ihre verwendung
|
|
SG11202001379WA
(en)
|
2017-09-08 |
2020-03-30 |
Bristol Myers Squibb Co |
Modified fibroblast growth factor 21 (fgf-21) for use in methods for treating nonalcoholic steatohepatitis (nash)
|
|
US11761963B2
(en)
|
2017-09-27 |
2023-09-19 |
Alexion Pharmaceuticals, Inc. |
Biomarker signature for predicting tumor response to anti-CD200 therapy
|
|
WO2019070917A1
(en)
|
2017-10-03 |
2019-04-11 |
The Schepens Eye Research Institute, Inc. |
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME
|
|
CN118512588A
(zh)
|
2017-10-26 |
2024-08-20 |
亚力兄制药公司 |
用于治疗阵发性夜间性血红蛋白尿(pnh)和非典型溶血性尿毒症综合征(ahus)的抗c5抗体的剂量和施用
|
|
WO2019089753A2
(en)
|
2017-10-31 |
2019-05-09 |
Compass Therapeutics Llc |
Cd137 antibodies and pd-1 antagonists and uses thereof
|
|
US11739326B2
(en)
|
2017-11-14 |
2023-08-29 |
Massachusetts Eye And Ear Infirmary |
RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
|
EP3713961A2
(de)
|
2017-11-20 |
2020-09-30 |
Compass Therapeutics LLC |
Cd137-antikörper und tumorantigenbindende antikörper sowie deren verwendung
|
|
CN111655206B
(zh)
|
2017-11-21 |
2022-10-14 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
KR20230020023A
(ko)
|
2018-03-14 |
2023-02-09 |
서피스 온콜로지, 인크. |
Cd39에 결합하는 항체 및 이의 용도
|
|
CN112512571B
(zh)
|
2018-03-22 |
2025-02-07 |
表面肿瘤学有限责任公司 |
抗il-27抗体及其用途
|
|
WO2019200357A1
(en)
|
2018-04-12 |
2019-10-17 |
Surface Oncology, Inc. |
Biomarker for cd47 targeting therapeutics and uses therefor
|
|
JP7366057B2
(ja)
|
2018-04-19 |
2023-10-20 |
チェックメイト ファーマシューティカルズ， インコーポレイテッド |
合成ｒｉｇ－ｉ様受容体アゴニスト
|
|
CA3099308A1
(en)
|
2018-05-21 |
2019-11-28 |
Compass Therapeutics Llc |
Compositions and methods for enhancing the killing of target cells by nk cells
|
|
WO2019226658A1
(en)
|
2018-05-21 |
2019-11-28 |
Compass Therapeutics Llc |
Multispecific antigen-binding compositions and methods of use
|
|
EP3802593B1
(de)
|
2018-05-31 |
2024-09-11 |
Alexion Pharmaceuticals, Inc. |
Dosierung und verabreichung von anti-c5 antikörpern zur behandlung von paroxysalen nocturalen hämoglobin-uria (pnh) in pädiatrischen patienten
|
|
EP3802603A1
(de)
|
2018-06-04 |
2021-04-14 |
Alexion Pharmaceuticals, Inc. |
Dosierung und verabreichung von anti-c5-antikörpern zur behandlung des atypischen hämolytisch-urämischen syndroms (ahus) bei kindern
|
|
US12312394B2
(en)
|
2018-06-28 |
2025-05-27 |
Alexion Pharmaceuticals, Inc. |
Methods of producing anti-C5 antibodies
|
|
WO2020018715A1
(en)
|
2018-07-17 |
2020-01-23 |
Massachusetts Institute Of Technology |
Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
|
|
WO2020033923A1
(en)
|
2018-08-09 |
2020-02-13 |
Compass Therapeutics Llc |
Antigen binding agents that bind cd277 and uses thereof
|
|
EP3833442A2
(de)
|
2018-08-09 |
2021-06-16 |
Compass Therapeutics LLC |
Antikörper zur bindung von cd277 und verwendungen davon
|
|
WO2020033925A2
(en)
|
2018-08-09 |
2020-02-13 |
Compass Therapeutics Llc |
Antibodies that bind cd277 and uses thereof
|
|
EP3873602B1
(de)
|
2018-10-30 |
2023-12-06 |
Alexion Pharmaceuticals, Inc. |
Subcutane dosierung und ztudienung von anti-c5-antikörpern zur behandlung der paroxysmalen nicht-turnalen hämoglobinurie (pnh)
|
|
EP3876924A4
(de)
|
2018-11-06 |
2022-08-10 |
Georgetown University |
Behandlung von nichtalkoholischer steatohepatitis mit cck-inhibitoren
|
|
US11046769B2
(en)
|
2018-11-13 |
2021-06-29 |
Compass Therapeutics Llc |
Multispecific binding constructs against checkpoint molecules and uses thereof
|
|
WO2020112816A1
(en)
|
2018-11-29 |
2020-06-04 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
EP3894440A4
(de)
|
2018-12-13 |
2022-09-07 |
Surface Oncology, Inc. |
Anti-il-27-antikörper und verwendungen davon
|
|
BR112021013571A2
(pt)
|
2019-01-16 |
2021-09-21 |
Compass Therapeutics Llc |
Formulações de anticorpos que se ligam a cd137 humano e usos das mesmas
|
|
WO2020163782A2
(en)
|
2019-02-08 |
2020-08-13 |
The Uab Research Foundation |
Immunotherapy for the treatment and prevention of inflammatory bowel disease
|
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
KR20220062500A
(ko)
|
2019-09-16 |
2022-05-17 |
서피스 온콜로지, 인크. |
항-cd39 항체 조성물 및 방법
|
|
MX2022003719A
(es)
|
2019-09-25 |
2022-04-26 |
Surface Oncology Inc |
Anticuerpos anti-il-27 y sus usos.
|
|
US20220356234A1
(en)
|
2019-10-02 |
2022-11-10 |
Alexion Pharmaceuticals, Inc. |
Complement inhibitors for treating drug-induced complement-mediated response
|
|
JP7707161B2
(ja)
|
2019-10-23 |
2025-07-14 |
チェックメイト ファーマシューティカルズ， インコーポレイテッド |
合成ｒｉｇ－ｉ様受容体アゴニスト
|
|
US11459389B2
(en)
|
2019-10-24 |
2022-10-04 |
Massachusetts Institute Of Technology |
Monoclonal antibodies that bind human CD161
|
|
US12084509B2
(en)
|
2020-04-30 |
2024-09-10 |
Duke University |
Gene signatures for monitoring acute rejection and methods of using same
|
|
JP2023525581A
(ja)
|
2020-05-15 |
2023-06-16 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
補体の活性化を検出するための細胞外小胞の使用方法、並びに補体性疾患の処置を評価及び／又は監視するためのその使用
|
|
JP7579594B2
(ja)
|
2020-05-15 |
2024-11-08 |
アイフロー・インコーポレーテッド |
哺乳類の眼の従来の房水排出路内の移植物のための方法及び装置
|
|
US12577621B2
(en)
|
2020-09-08 |
2026-03-17 |
Duke University |
LRRK2 mutations as biomarkers for the prediction of immune checkpoint response in cancer
|
|
US12496612B2
(en)
|
2021-01-08 |
2025-12-16 |
Surmodics, Inc. |
Coating application system and methods for coating rotatable medical devices
|
|
WO2022236134A1
(en)
|
2021-05-07 |
2022-11-10 |
Surface Oncology, Inc. |
Anti-il-27 antibodies and uses thereof
|
|
WO2022251446A1
(en)
|
2021-05-28 |
2022-12-01 |
Alexion Pharmaceuticals, Inc. |
Methods for detecting cm-tma biomarkers
|
|
WO2023283281A1
(en)
|
2021-07-07 |
2023-01-12 |
Genentech, Inc. |
Rod inserter system and methods
|
|
US20250049758A1
(en)
|
2021-12-06 |
2025-02-13 |
Breye Therapeutics Aps |
Danegaptide Formulation for Application in the Eye
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
US20240026001A1
(en)
|
2022-05-25 |
2024-01-25 |
Surface Oncology, Inc. |
Use of anti-il-27 antibodies
|
|
US20240025987A1
(en)
|
2022-05-25 |
2024-01-25 |
Surface Oncology, Inc. |
Use of anti-il-27 antibodies
|
|
EP4583911A1
(de)
|
2022-09-06 |
2025-07-16 |
Alexion Pharmaceuticals, Inc. |
Diagnostische und prognostische biomarkerprofile bei patienten mit hämatopoetischer stammzelltransplantationsassoziierter thrombotischer mikroangiopathie (hsct-tma)
|
|
WO2024238422A1
(en)
|
2023-05-12 |
2024-11-21 |
Alexion Pharmaceuticals, Inc. |
Use of a panel of lectins for detection of complement biomarkers in urine extracellular vesicles
|
|
WO2024238421A1
(en)
|
2023-05-12 |
2024-11-21 |
Alexion Pharmaceuticals, Inc. |
Use of biomarkers for the identification and treatment of complement-mediated disorders
|
|
WO2026055167A1
(en)
|
2024-09-05 |
2026-03-12 |
Surface Oncology, LLC |
Anti-il-27 antibodies and use of biomarkers in uses thereof
|
|
WO2026055168A1
(en)
|
2024-09-06 |
2026-03-12 |
Surface Oncology, LLC |
Anti-il-27 antibodies and uses and doses thereof
|